Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Fidelity And T. Rowe Price Score Big On These 'New' Blue Chips

Both Fidelity and T. Rowe Price ETFs are both cashing in on "blue chips." But these aren't the S&P 500 blue chips of yore you might think of.

Investors Business Daily

Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower

Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower

Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.

Investors Business Daily

3 Stocks Most Likely to Join the $1 Trillion Market Cap Club in the Next 5 Years

3 Stocks Most Likely to Join the $1 Trillion Market Cap Club in the Next 5 Years

With a solid product portfolio, brand strength, and a thirst for innovation, these three companies are on the right track.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Alzheimer's drug that can slow disease gets backing from FDA advisers

Federal health advisers have endorsed a closely watched Alzheimer’s drug from Eli Lilly for people with mild dementia

The Independent UK

FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug

Eli Lilly stock jumped Monday after FDA advisors said the benefits of Alzheimer's treatment donanemab outweigh the risks for most patients.

Investors Business Daily

Dow Jones Futures Fall; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

The stock market is at highs with Apple's AI push, the Fed rate "dot-plot" and the Tesla shareholder meeting headlining key events and news.

Investors Business Daily

Structure Therapeutics vs. Viking Therapeutics: Which Weight-Loss Drug Stock Wins?

With weight-loss drugs gaining traction, which biopharma stock wins?

inkl

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly Stock: Is LLY Outperforming the Healthcare Sector?

Eli Lilly Stock: Is LLY Outperforming the Healthcare Sector?

Eli Lilly has outperformed the healthcare sector over the past three months, but analysts remain cautiously optimistic about the stock’s prospects.

In China, weight-loss drugs are becoming big business

In China, weight-loss drugs are becoming big business

Chinese pharmaceutical companies are racing to roll out weight-loss drugs amid the popularity of Ozempic.

Mutual Funds Keep Buying Up Google, These 2 Other Big Caps

Mutual Funds Keep Buying Up Google, These 2 Other Big Caps

Google stock is a mutual fund favorite and is near a buy point. Two other leading growth stocks top the list of fund favorites.

Investors Business Daily

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

Madrigal stock plummeted Wednesday on detailed results from a study of Eli Lilly's weight-loss drug in patients with a serious liver disease.

Investors Business Daily

Alphabet Picks Eli Lilly Executive Anat Ashkenazi As New CFO

Alphabet Picks Eli Lilly Executive Anat Ashkenazi As New CFO

Google-parent Alphabet announced that its new chief financial officer will be Anat Ashkenazi, currently an executive at pharmaceutical company Eli Lilly.

Investors Business Daily

Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In Spotlight

Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In Spotlight

As Nvidia stock takes aim at another record high and market-cap dominance, AMD and TSM set up alongside two top drugmakers.

Investors Business Daily

3 Pharma Stocks Poised for Big Returns This Summer

3 Pharma Stocks Poised for Big Returns This Summer

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs and the incorporation of cutting-edge technologies into drug manufacturing. Hence, pharma stocks Eli Lilly (LLY), Green Thumb Industries (GTBIF), and Supernus Pharmaceuticals (SUPN) might be worth buying for returns this summer. Read more….

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

S&P 500 Giants Lead Five Healthy Stocks Near Buy Points

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

One Ozempic patient reveals major drug-powered weight loss truths

As medicines for losing weight become more widely accessed and affordable, people are discussing their experiences.

Do Wall Street Analysts Like Eli Lilly Stock?

Eli Lilly stock has outperformed the broader market over the past year, and Wall Street analysts remain optimistic about the stock’s prospect.

Investors Business Daily

Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds

Costco stock is in a buy zone ahead of the earnings report Thursday. Mutual funds like this stock and a few others.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall, But Nvidia Leads Techs Higher; 7 Stocks Near Buy Points

The market rally had a mixed week as breadth narrowed. Microsoft and Merck led stocks near buy points. Here's what to do.

Eli Lilly (LLY) vs. Novo Nordisk (NVO): Which Pharma Stock Is Driving Long-Term 2024 Profits?

The pharmaceutical market is poised for rapid expansion due to rising global medical needs and increasing integration of technologies in drug discovery and development. Amid this, let’s analyze Eli Lilly (LLY) and Novo Nordisk (NVO) to determine which pharma stock will drive long-term profits in 2024. Read more to find…

Investors Business Daily

Eight Massive ETFs With Billions In Assets Are Beating The S&P 500

You don't need to gamble on tiny ETFs with scant assets to beat the S&P 500. Turns out you can do it just fine with massive ones.

Weight-loss drugs: How low costs, easy access change the game now

Pharmaceutical CEO George Hampton discusses anti-obesity medications and the quickly moving acceleration of their affordability and accessibility.

It's Time for Over-the-Counter Ozempic

There's an easy way to lower the cost of next-generation weight-loss drugs.

Investors Business Daily

Dow Jones Futures Fall As Target Tumbles; Nvidia Looms Over Stock Market

The Nasdaq hit a new high Tuesday but Target tumbled early Wednesday. Will Nvidia earnings tonight meet lofty hopes?

Investors Business Daily

IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High

Eli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising test results for a Crohn's treatment.

1 … 7 8 9 10

People

Christopher Waller

Todd Rosenbluth

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

243,919 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play